Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
Peter M.K. Westcott, Nathan Sacks, Jason M. Schenkel, et al.
Nature Cancer (2021) Vol. 2, Iss. 10, pp. 1071-1085
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Therapeutic cancer vaccines: advancements, challenges and prospects
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 179
Patient-derived xenograft models in cancer therapy: technologies and applications
Yihan Liu, Wantao Wu, Changjing Cai, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
Peter M.K. Westcott, Francesc Muyas, Haley Hauck, et al.
Nature Genetics (2023) Vol. 55, Iss. 10, pp. 1686-1695
Open Access | Times Cited: 79
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
Maria M. Steele, Abhinav Jaiswal, Ines Delclaux, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 664-675
Open Access | Times Cited: 77
Localization, tissue biology and T cell state — implications for cancer immunotherapy
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 57
The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 57
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
Feng Wang, Ying Jin, Min Wang, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1035-1043
Closed Access | Times Cited: 49
SOX17 enables immune evasion of early colorectal adenomas and cancers
Norihiro Goto, Peter M.K. Westcott, Saori Goto, et al.
Nature (2024) Vol. 627, Iss. 8004, pp. 636-645
Closed Access | Times Cited: 40
Regulation and impact of tumor-specific CD4+ T cells in cancer and immunotherapy
Mengdi Guo, M. Liu, David G. Brooks
Trends in Immunology (2024) Vol. 45, Iss. 4, pp. 303-313
Closed Access | Times Cited: 18
From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy
Sikiru O. Imodoye, Kamoru A. Adedokun, Ibrahim O. Bello
Histochemistry and Cell Biology (2024) Vol. 161, Iss. 4, pp. 299-323
Closed Access | Times Cited: 16
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 15
Cancer immune evasion, immunoediting and intratumour heterogeneity
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 5
High‐Z‐Sensitized Radiotherapy Synergizes with the Intervention of the Pentose Phosphate Pathway for In Situ Tumor Vaccination
Yuxiang Wang, Jing Chen, R. Duan, et al.
Advanced Materials (2022) Vol. 34, Iss. 13
Closed Access | Times Cited: 64
Deciphering the immunopeptidome in vivo reveals new tumour antigens
Alex M. Jaeger, Lauren Stopfer, Ryuhjin Ahn, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 149-155
Open Access | Times Cited: 64
Therapeutic vaccines for breast cancer: Has the time finally come?
Chiara Corti, Pier Paolo Maria Berton Giachetti, Alexander M.M. Eggermont, et al.
European Journal of Cancer (2021) Vol. 160, pp. 150-174
Open Access | Times Cited: 62
Radiation therapy-induced remodeling of the tumor immune microenvironment
Maud Charpentier, Sheila Spada, Samantha J. Van Nest, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 737-747
Open Access | Times Cited: 62
Oral Nanomotor‐Enabled Mucus Traverse and Tumor Penetration for Targeted Chemo‐Sono‐Immunotherapy against Colon Cancer
Yingui Cao, Shengsheng Liu, Ya Ma, et al.
Small (2022) Vol. 18, Iss. 42
Closed Access | Times Cited: 60
Strategies to overcome DC dysregulation in the tumor microenvironment
Guillaume Mestrallet, Kazuki Sone, Nina Bhardwaj
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy
Giulia Escobar, Katherine Tooley, Joan Pagès Oliveras, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1662-1679.e7
Open Access | Times Cited: 32
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
Joseph S. Dolina, Joey Lee, Spencer E. Brightman, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 17
Open Access | Times Cited: 27
Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review
Mina Hosseini, Simin Seyedpour, Behzad Khodaei, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 146-146
Open Access | Times Cited: 25
Cellular and molecular waypoints along the path of T cell exhaustion
Xin Lan, Caitlin C. Zebley, Ben Youngblood
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 24
Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement
Xin Lan, Mi Tian, Shanta Alli, et al.
Nature Immunology (2024) Vol. 25, Iss. 6, pp. 1046-1058
Closed Access | Times Cited: 12
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 10
Neoantigens in cancer immunotherapy: focusing on alternative splicing
Peng Huang, Feng Wen, Nuerye Tuerhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top